Atomic Force Microscopic Studies of Dissecting Aneurysm

夹层动脉瘤的原子力显微镜研究

基本信息

  • 批准号:
    8492971
  • 负责人:
  • 金额:
    $ 23.18万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2015-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The industrial chemical N-(2-aminoethyl) ethanolamine (AEEA) has enormous worldwide production and use. Human environmental exposures to AEEA occur, and AEEA is found in a variety of common products. Blood vessels are the target of many environmental toxins. Furthermore, it is becoming increasingly recognized that vascular disorders begin in childhood, and may be related to prenatal exposure. This and other laboratories have found that AEEA, given to pregnant rats (dams) during their third trimester, results in a vascular lesion in newborn pups known as dissecting aortic aneurysm, or DAA. DAA is the sudden tearing, or splitting of the layers of the muscular wall of the thoracic aorta. In humans, DAA affects those in the teen years to early adulthood, resulting in occlusion of distal vessels, aortic rupture, and sudden death. DAA is associated with several well-described clinical syndromes, but the vast majority of DAAs occur sporadically, without known genetic defects, and with hypertension as the only clear-cut risk factor. The long-term goal of this proposed research is to better understand the physical weakening of the aortic wall that underlies arterial dissection; by understanding these mechanisms in this in vivo model, in vascular cells, and in spontaneously hypertensive rats, strategies for diagnosis and prevention of human DAA can be devised. The hypothesis to be tested is that AEEA's toxic insult causes damaged, dysfunctional fetal collagen fibrillogenesis by vascular smooth muscle cells (VSMCs) of the aortic wall (or media). Deranged biophysical properties and weakening of the blood vessel wall result. The rationale for the proposed studies is that by understanding the physical and molecular defects that lead to dissection, strategies to prevent or attenuate DAA can be devised. The hypothesis will be addressed by two Specific Aims: First, physical defects in the aorta's major structural proteins (collagen; elastin) will be defined after in vivo or in vitro AEE exposure. This will be accomplished by measuring physical characteristics of aortic matrix and isolated molecules with atomic force microscopy (AFM), a technique that measures piconewton molecular forces. In Specific Aim #2, mechanisms underlying vascular dissection and the role of hypertension (a risk factor in humans) will be revealed by: a) characterizing defects from matrix produced by isolated VSMCs through biochemical and molecular techniques, and b) defining prenatal AEEA effects in control and spontaneously hypertensive rats. These combined in vivo, in vitro, biophysical and molecular approaches will identify the structural/molecular toxic effects of AEEA that weaken the aortic wall to result in DAA.
描述(由申请人提供):工业化学品N-(2-氨乙基)乙醇胺(AEEA)在世界范围内具有巨大的生产和使用。人类环境暴露于AEEA,AEEA存在于各种常见产品中。血管是许多环境毒素的目标。此外,人们越来越认识到,血管疾病开始在儿童时期,并可能与产前暴露。该实验室和其他实验室发现,在妊娠大鼠(母鼠)的第三个三个月期间给予AEEA,会导致新生幼崽的血管病变,称为夹层主动脉瘤或DAA。DAA是胸主动脉肌壁层的突然撕裂或分裂。在人类中,DAA影响青少年至成年早期的人,导致远端血管闭塞、主动脉破裂和猝死。DAA与几种描述良好的临床综合征相关,但绝大多数DAA是偶发性的,没有已知的遗传缺陷,高血压是唯一明确的风险因素。这项拟议研究的长期目标是更好地了解动脉夹层背后的主动脉壁的物理弱化;通过了解这种体内模型、血管细胞和自发性高血压大鼠中的这些机制,可以设计出诊断和预防人类DAA的策略。待检验的假设是AEEA的毒性损伤导致主动脉壁(或中膜)的血管平滑肌细胞(VSMC)的受损、功能障碍的胎儿胶原原纤维形成。导致生物物理特性紊乱和血管壁弱化。提出的研究的基本原理是,通过了解导致夹层的物理和分子缺陷,可以设计预防或减轻DAA的策略。该假设将通过两个特定目的来解决:首先,在体内或体外AEE暴露后,将定义主动脉主要结构蛋白(胶原蛋白;弹性蛋白)的物理缺陷。这将通过用原子力显微镜(AFM)测量主动脉基质和分离分子的物理特性来实现,原子力显微镜是一种测量皮牛顿分子力的技术。在具体目标#2中,将通过以下方式揭示血管夹层和高血压(人类风险因素)作用的潜在机制:a)通过生物化学和分子技术表征分离的VSMC产生的基质缺陷,和B)定义对照和自发性高血压大鼠中的产前AEEA效应。这些结合体内、体外、生物物理学和分子学的方法将确定结构/分子毒性效应 削弱主动脉壁导致DAA的AEEA。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

PAUL J BOOR其他文献

PAUL J BOOR的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('PAUL J BOOR', 18)}}的其他基金

Atomic Force Microscopic Studies of Dissecting Aneurysm
夹层动脉瘤的原子力显微镜研究
  • 批准号:
    8668960
  • 财政年份:
    2013
  • 资助金额:
    $ 23.18万
  • 项目类别:
Fetal Basis of Dissecting Aortic Aneurysm
主动脉夹层动脉瘤的胎儿基础
  • 批准号:
    7036519
  • 财政年份:
    2004
  • 资助金额:
    $ 23.18万
  • 项目类别:
Fetal Basis of Dissecting Aortic Aneurysm
主动脉夹层动脉瘤的胎儿基础
  • 批准号:
    6885413
  • 财政年份:
    2004
  • 资助金额:
    $ 23.18万
  • 项目类别:
Fetal Basis of Dissecting Aortic Aneurysm
主动脉夹层动脉瘤的胎儿基础
  • 批准号:
    6792928
  • 财政年份:
    2004
  • 资助金额:
    $ 23.18万
  • 项目类别:
GSTs: Oxidative Stress in Early Atherosclerosis
GST:早期动脉粥样硬化中的氧化应激
  • 批准号:
    6866427
  • 财政年份:
    2002
  • 资助金额:
    $ 23.18万
  • 项目类别:
GSTs: Oxidative Stress in Early Atherosclerosis
GST:早期动脉粥样硬化中的氧化应激
  • 批准号:
    6719055
  • 财政年份:
    2002
  • 资助金额:
    $ 23.18万
  • 项目类别:
GSTs: Oxidative Stress in Early Atherosclerosis
GST:早期动脉粥样硬化中的氧化应激
  • 批准号:
    7030963
  • 财政年份:
    2002
  • 资助金额:
    $ 23.18万
  • 项目类别:
GSTs: Oxidative Stress in Early Atherosclerosis
GST:早期动脉粥样硬化中的氧化应激
  • 批准号:
    6473227
  • 财政年份:
    2002
  • 资助金额:
    $ 23.18万
  • 项目类别:
GSTs: Oxidative Stress in Early Atherosclerosis
GST:早期动脉粥样硬化中的氧化应激
  • 批准号:
    6624246
  • 财政年份:
    2002
  • 资助金额:
    $ 23.18万
  • 项目类别:
CELLULAR AND MOLEC STUDIES OF ABDOMINAL AORTIC ANEURYSM
腹主动脉瘤的细胞和分子研究
  • 批准号:
    6129877
  • 财政年份:
    2000
  • 资助金额:
    $ 23.18万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 23.18万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了